SCHEMBL6985813

SCHEMBL6985813

OCC1COc2cccc(O)c2O1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 4/20 0.49
ADRA1D P25100 3/20 0.49
ADRA1B P35368 3/20 0.49
CA2 P00918 3/20 0.44
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
HTT P42858 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD1 P21728 1/20 0.39
TBXA2R P21731 1/20 0.39
SLC6A2 P23975 1/20 0.39
DRD3 P35462 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MTNR1A P48039 1/20 0.37
ALOX15 P16050 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985807 1.00 ADRA1A (0.49) ADRA1AADRA1DADRA1BCA2CHRNB4
SCHEMBL6981984 0.83 CA2 (0.41) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL6974656 0.83 ADRA1A (0.47) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL1021052 0.83 ADRA1A (0.47) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL6981978 0.83 CA2 (0.41) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL6982180 0.82 CA2 (0.59) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL6982176 0.82 CA2 (0.59) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL4961821 0.82 CA2 (0.40) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL4961826 0.82 CA2 (0.40) ADRA1AADRA1DADRA1BCA2HTT
SCHEMBL6977481 0.81 CA2 (0.42) ADRA1AADRA1DADRA1BCA2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
CN-1052723-C Bicyclic aromatic compounds as therapeutic agents KNOLL AG (DE) 2000-05-24 CN disclosed
EP-0717739-B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses KNOLL AG (DE) 2000-03-29 EP disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
US-5767116-A TREATING PSYCHOSES KNOLL ATKIENGESELLSCHAFT (DE) 1998-06-16 US disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
US-5605896-A Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1997-02-25 US disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed
CN-1133043-A Bicyclic aromatic compounds as therapeutic agents BOOTS CO PLC (DE) 1996-10-09 CN disclosed
EP-0717739-A1 BICYCLIC AROMATIC COMPOUNDS AS THERAPEUTIC AGENTS Knoll AG (DE) 1996-06-26 EP disclosed
US-5474994-A Treating hypertension, urethral and lower urinary tract contractions RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-12-12 US disclosed
EP-0210581-B1 1,4-benzodioxane derivatives, process for preparing them, pharmacological composition and use EISAI CO LTD (JP) 1995-07-05 EP disclosed
WO-1995007274-A1 BICYCLIC AROMATIC COMPOUNDS AS THERAPEUTIC AGENTS KNOLL AG (DE) 1995-03-16 WO disclosed
US-4959376-A ANTIISCHEMIC AGENTS, HYPOTENSIVE AGENTS EISAI CO., LTD. (JP) 1990-09-25 US disclosed
EP-0307970-A1 1,4-Benzodioxane derivatives, process for preparing them, pharmacological composition and use Eisai Co., Ltd. (JP) 1989-03-22 EP disclosed
US-4794118-A ANTIISCHEMIC AGENTS; CARDIOVASCULAR DISORDERS; BLOOD PRESSURE CONTROL IN SURGERY EISAI CO., LTD. (JP) 1988-12-27 US disclosed
EP-0210581-A1 1,4-benzodioxane derivatives, process for preparing them, pharmacological composition and use Eisai Co., Ltd. (JP) 1987-02-04 EP disclosed